Subpart D - Clinical Toxicology Test Systems
- § 862.3030 Acetaminophen test system
- § 862.3035 Amikacin test system
- § 862.3040 Alcohol test system
- § 862.3050 Breath-alcohol test system
- § 862.3080 Breath nitric oxide test system
- § 862.3100 Amphetamine test system
- § 862.3110 Antimony test system
- § 862.3120 Arsenic test system
- § 862.3150 Barbiturate test system
- § 862.3170 Benzodiazepine test system
- § 862.3200 Clinical toxicology calibrator
- § 862.3220 Carbon monoxide test system
- § 862.3240 Cholinesterase test system
- § 862.3250 Cocaine and cocaine metabolite test system
- § 862.3270 Codeine test system
- § 862.3280 Clinical toxicology control material
- § 862.3300 Digitoxin test system
- § 862.3320 Digoxin test system
- § 862.3350 Diphenylhydantoin test system
- § 862.3360 Drug metabolizing enzyme genotyping system
- § 862.3380 Ethosuximide test system
- § 862.3450 Gentamicin test system
- § 862.3520 Kanamycin test system
- § 862.3550 Lead test system
- § 862.3555 Lidocaine test system
- § 862.3560 Lithium test system
- § 862.3580 Lysergic acid diethylamide (LSD) test system
- § 862.3590 Meprobamate test system
- § 862.3600 Mercury test system
- § 862.3610 Methamphetamine test system
- § 862.3620 Methadone test system
- § 862.3630 Methaqualone test system
- § 862.3640 Morphine test system
- § 862.3645 Neuroleptic drugs radioreceptor assay test system
- § 862.3650 Opiate test system
- § 862.3652 Organophosphate test system
- § 862.3660 Phenobarbital test system
- § 862.3670 Phenothiazine test system
- § 862.3680 Primidone test system
- § 862.3700 Propoxyphene test system
- § 862.3750 Quinine test system
- § 862.3800 Reagents for molecular diagnostic instrument test systems
- § 862.3830 Salicylate test system
- § 862.3840 Sirolimus test system
- § 862.3850 Sulfonamide test system
- § 862.3870 Cannabinoid test system
- § 862.3880 Theophylline test system
- § 862.3900 Tobramycin test system
- § 862.3910 Tricyclic antidepressant drugs test system
- § 862.3950 Vancomycin test system